Safety and tolerance of the ketogenic diet in patients with Zellweger Syndrome

被引:0
作者
Stephanie, Borst [1 ]
Michael, Ciliberto [2 ]
Sreenath, Thati Ganganna [2 ]
机构
[1] Univ Iowa, 225 S Grand Ave, Iowa City, IA 52242 USA
[2] Univ Iowa, Stead Family Childrens Hosp, 200 Hawkins Dr, Iowa City, IA 52242 USA
关键词
Epilepsy; Ketogenic Diet; Zellweger Syndrome; Peroxisomal Disorder; CHAIN FATTY-ACIDS; PHYTANIC ACID;
D O I
10.1016/j.ebr.2024.100655
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Zellweger Syndrome is a peroxisomal disorder that can lead to elevation of long chain fatty acids and epilepsy, which can be drug resistant. The treatment of drug resistant epilepsy can include the ketogenic diet in appropriately chosen patients. Typically, the ketogenic diet is contraindicated in individuals with defects in fatty acid metabolism because of the diet's reliance on medium and long chain fatty acids. To our knowledge this is the first publication outlining the use of the ketogenic diet in patients with defects in beta oxidation of very long chain fatty acids. We present two patients with Zellweger Syndrome who were placed on a ketogenic diet for drug resistant epilepsy. Safety and tolerance of the ketogenic diet in patients with Zellweger Syndrome.
引用
收藏
页数:3
相关论文
共 12 条
  • [1] Cholbam® and Zellweger spectrum disorders: treatment implementation and management
    Anderson, Janaina Nogueira
    Ammous, Zineb
    Eroglu, Yasemen
    Hernandez, Erick
    Heubi, James
    Himes, Ryan
    Palle, Sirish
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [2] Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines
    Braverman, Nancy E.
    Raymond, Gerald V.
    Rizzo, William B.
    Moser, Ann B.
    Wilkinson, Mark E.
    Stone, Edwin M.
    Steinberg, Steven J.
    Wangler, Michael F.
    Rush, Eric T.
    Hacia, Joseph G.
    Bose, Mousumi
    [J]. MOLECULAR GENETICS AND METABOLISM, 2016, 117 (03) : 313 - 321
  • [3] Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy
    Kim, Jeong A.
    Yoon, Jung-Rim
    Lee, Eun Joo
    Lee, Joon Soo
    Kim, Jeong Tae
    Kim, Heung Dong
    Kang, Hoon-Chul
    [J]. EPILEPSIA, 2016, 57 (01) : 51 - 58
  • [4] Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group
    Kossoff, Eric H.
    Zupec-Kania, Beth A.
    Amark, Per E.
    Ballaban-Gil, Karen R.
    Bergqvist, A. G. Christina
    Blackford, Robyn
    Buchhalter, Jeffrey R.
    Caraballo, Roberto H.
    Cross, J. Helen
    Dahlin, Maria G.
    Donner, Elizabeth J.
    Klepper, Joerg
    Jehle, Rana S.
    Kim, Heung Dong
    Liu, Y. M. Christiana
    Nation, Judy
    Nordli, Douglas R., Jr.
    Pfeifer, Heidi H.
    Rho, Jong M.
    Stafstrom, Carl E.
    Thiele, Elizabeth A.
    Turner, Zahava
    Wirrell, Elaine C.
    Wheless, James W.
    Veggiotti, Pierangelo
    Vining, Eileen P. G.
    [J]. EPILEPSIA, 2009, 50 (02) : 304 - 317
  • [5] Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry
    Longo, Raffaella
    Peri, Carolina
    Cricri, Dalma
    Coppi, Lara
    Caruso, Donatella
    Mitro, Nico
    De Fabiani, Emma
    Crestani, Maurizio
    [J]. NUTRIENTS, 2019, 11 (10)
  • [6] Ketogenic diet for the treatment of pediatric epilepsy: review and meta-analysis
    Sourbron, Jo
    Klinkenberg, Sylvia
    van Kuijk, Sander M. J.
    Lagae, Lieven
    Lambrechts, Danielle
    Braakman, Hilde M. H.
    Majoie, Marian
    [J]. CHILDS NERVOUS SYSTEM, 2020, 36 (06) : 1099 - 1109
  • [7] The Impact of a Ketogenic Diet and Liver Dysfunction on Serum Very Long-Chain Fatty Acids Levels
    Stradomska, T. J.
    Bachanski, M.
    Pawlowska, J.
    Syczewska, M.
    Stolarczyk, A.
    Tylki-Szymanska, A.
    [J]. LIPIDS, 2013, 48 (04) : 405 - 409
  • [8] Epilepsy in peroxisomal diseases
    Takahashi, Y
    Suzuki, Y
    Kumazaki, K
    Tanabe, Y
    Akaboshi, S
    Miura, K
    Shimozawa, N
    Kondo, N
    Nishiguchi, T
    Terada, K
    Orii, T
    [J]. EPILEPSIA, 1997, 38 (02) : 182 - 188
  • [9] Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders
    Takemoto, Y
    Suzuki, Y
    Horibe, R
    Shimozawa, N
    Wanders, RJA
    Kondo, N
    [J]. BRAIN & DEVELOPMENT, 2003, 25 (07) : 481 - 487
  • [10] Phytanic acid metabolism in health and disease
    Wanders, Ronald J. A.
    Komen, Jasper
    Ferdinandusse, Sacha
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2011, 1811 (09): : 498 - 507